MedPath

A Study Comparing Two Types of Dental Anesthesia for numbing children teeth

Not yet recruiting
Conditions
Other and unspecified diseases ofpulp and periapical tissues,
Registration Number
CTRI/2025/05/087625
Lead Sponsor
Ashish Suresh
Brief Summary

Effective pain management is a crucial aspect of pediatric dentistry, as it directly affects a child’s comfort, cooperation, and overall experience during dental procedures. Achieving adequate anesthesia is essential for minimizing discomfort and anxiety, allowing for smoother treatments. Local anesthetics play a key role in pain control, with lidocaine being the most commonly used due to its well-established safety and efficacy. However, articaine has gained attention in recent years because of its enhanced diffusion ability, which may provide better anesthesia, particularly in areas with dense bone.

One technique that has been introduced to improve the effectiveness of local anesthetics is buffering, which involves adjusting the anesthetic solution’s pH to be closer to physiological levels. This method has been found to decrease injection pain, speed up the onset of anesthesia, and enhance its overall performance by increasing the availability of active anesthetic molecules. Although both articaine and lidocaine can be buffered, limited research has directly compared their effectiveness in pediatric patients.

This study aims to evaluate the clinical efficacy of buffered 4% articaine versus buffered 2% lidocaine in pediatric dental procedures using a randomized crossover split-mouth design. The primary focus will be on anesthetic onset time, pain perception during injection, and the duration of anesthesia. By analyzing these factors, the study seeks to determine whether buffered articaine provides any significant advantages over buffered lidocaine, offering insights that may help improve pain management strategies in pediatric dentistry

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria
  • 1.Children who are between 6 to 12 years old 2.Healthy children (ASA I) 3.Body weight within the Inter Quartile Range (IQR) for this age group as defined by the Centers for Disease Control and Prevention 4.Willingness to participate in two sessions 5.No history of adverse reaction to anesthetic.
  • 6.Children with no Physical or Cognitive disablities 7.Patient reporting to the dental operatory for the first time to minimize behavioural bias 8.Children requiring pulp therapy procedures.
Exclusion Criteria

1.Allergy to lidocaine anesthetic drugs 2.Local anesthetic drug administered within the week before the session in which they participated 3.Highly symptomatic teeth 4.Localised Lesion at the site of infection 5.Children with prior dental experience 6.Patients with developmental or linguistic disorders who cannot communicate properly 7.Children with medications which affect behaviour 8.Medically and systematically compromised patients 9.Patients with cognitive impairments or special needs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain perception using VAS and FLACC scaleAt baseline
Secondary Outcome Measures
NameTimeMethod
The start of the action, duration of postoperative analgesia, & occurrence of any problems. The duration ofanesthesia was assessed by the feeling of numbness & the first sign of pain.

Trial Locations

Locations (1)

Saveetha Dental College and Hospitals

🇮🇳

Thiruvallur, TAMIL NADU, India

Saveetha Dental College and Hospitals
🇮🇳Thiruvallur, TAMIL NADU, India
Dr Ashish Suresh
Principal investigator
9884927585
152411001.sdc@saveetha.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.